ECVT Stock Analysis: Ecovyst | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 1.099m USD | 12M Return: 14.5% | US27923Q1094 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.0M
EPS Trend: -21.8%
Qual. Beats: 0
Rev. Trend: 78.9%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ecovyst Inc. (NYSE: ECVT) is a U.S.-based specialty chemicals company that produces and distributes virgin and regenerated sulfuric acid, serving customers in the United States and internationally. Its products and end-to-end logistics support alkylate production for refineries, as well as mining, water treatment, and broader industrial applications.
The company was founded in 1831 and is headquartered in Wayne, Pennsylvania. It was previously known as PQ Group Holdings Inc. and adopted the Ecovyst name in August 2021, the same month of its IPO.
Ecovyst operates within the Materials sector, and its business model combines virgin acid production with acid regeneration services, where spent sulfuric acid from refinery and chemical customers is reclaimed and reused. Sulfuric acid is one of the most widely consumed industrial chemicals globally, primarily used in fertilizer manufacturing, mineral processing, and petroleum refining.
- Sulfuric acid pricing tracks phosphate fertilizer and mining demand
- Zeolite catalyst demand grows on tightening global emissions regulations
- Energy and sulfur raw material costs pressure product margins
| Net Income: -61.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.40 > 1.0 |
| NWC/Revenue: 12.40% < 20% (prev 21.26%; Δ -8.86% < -1%) |
| CFO/TA 0.10 > 3% & CFO 148.3m > Net Income -61.3m |
| Net Debt (512.0m) to EBITDA (213.1m): 2.40 < 3 |
| Current Ratio: 1.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (110.8m) vs 12m ago -4.89% < -2% |
| Gross Margin: 21.04% > 18% (prev 24.51%; Δ -3.48% > 0.5%) |
| Asset Turnover: 54.04% > 50% (prev 39.21%; Δ 14.83% > 0%) |
| Interest Coverage Ratio: 3.28 > 6 (EBIT TTM 79.0m / Interest Expense TTM 24.1m) |
| A: 0.08 (Total Current Assets 261.3m - Total Current Liabilities 153.5m) / Total Assets 1.42b |
| B: -0.17 (Retained Earnings -236.5m / Total Assets 1.42b) |
| C: 0.05 (EBIT TTM 79.0m / Avg Total Assets 1.61b) |
| D: 0.70 (Book Value of Equity 586.9m / Total Liabilities 833.8m) |
| Altman-Z'' = 1.02 = BB |
| DSRI: 0.88 (Receivables 112.9m/103.5m, Revenue 869.3m/704.4m) |
| GMI: 1.17 (GM 24.51% / 21.04%) |
| AQI: 0.82 (AQ_t 0.40 / AQ_t-1 0.49) |
| SGI: 1.23 (Revenue 869.3m / 704.4m) |
| TATA: -0.15 (NI -61.3m - CFO 148.3m) / TA 1.42b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of October 05, 2026, the stock is trading at USD 10.12 with a total of 1,078,651 shares traded. Over the past week, the price has changed by -0.20%, over one month by -2.41%, over three months by -14.45% and over the past year by +14.48%.
Current recommended Stop Loss: 9.50 (which is 6.1% or 2.1 ATR below the current price).
Ecovyst has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy ECVT.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 15.2 | 49.9% |
P/E Trailing = 43.6522
P/E Forward = 13.459
P/S = 1.2644
P/B = 1.9266
Revenue TTM = 869.3m USD
EBIT TTM = 79.0m USD
EBITDA TTM = 213.1m USD
Long Term Debt = 493.0m USD (from longTermDebt, last quarter)
Short Term Debt = 13.2m USD (from shortTermDebt, last quarter)
Debt = 599.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 53.4m
Net Debt = 512.0m USD (calculated: Debt 599.8m - CCE 87.8m)
Enterprise Value = 1.61b USD (1.10b + Debt 599.8m - CCE 87.8m)
Interest Coverage Ratio = 3.28 (Ebit TTM 79.0m / Interest Expense TTM 24.1m)
EV/FCF = 22.31x (Enterprise Value 1.61b / FCF TTM 72.2m)
FCF Yield = 4.48% (FCF TTM 72.2m / Enterprise Value 1.61b)
FCF Margin = 8.31% (FCF TTM 72.2m / Revenue TTM 869.3m)
Net Margin = -7.05% (Net Income TTM -61.3m / Revenue TTM 869.3m)
Gross Margin = 21.04% ((Revenue TTM 869.3m - Cost of Revenue TTM 686.4m) / Revenue TTM)
Gross Margin QoQ = 19.92% (prev 15.94%)
Tobins Q-Ratio = 1.13 (Enterprise Value 1.61b / Total Assets 1.42b)
Interest Expense / Debt = 4.01% (Interest Expense 24.1m / Debt 599.8m)
Taxrate = 28.19% (4.20m / 14.9m)
NOPAT = 56.8m (EBIT 79.0m * (1 - 28.19%))
Current Ratio = 1.70 (Total Current Assets 261.3m / Total Current Liabilities 153.5m)
Debt / Equity = 1.02 (Debt 599.8m / totalStockholderEquity, last quarter 586.9m)
Debt / EBITDA = 2.40 (Net Debt 512.0m / EBITDA 213.1m)
Debt / FCF = 7.09 (Net Debt 512.0m / FCF TTM 72.2m)
Total Stockholder Equity = 593.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.81% (Net Income -61.3m / Total Assets 1.42b)
RoE = -10.33% (Net Income TTM -61.3m / Total Stockholder Equity 593.4m)
RoCE = 7.28% (EBIT 79.0m / Capital Employed (Equity 593.4m + L.T.Debt 493.0m))
RoIC = 4.59% (NOPAT 56.8m / Invested Capital 1.24b)
WACC = 7.18% (E(1.10b)/V(1.70b) * Re(9.52%) + D(599.8m)/V(1.70b) * Rd(4.01%) * (1-Tc(0.28)))
Discount Rate = 9.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.75 | Cagr: -2.54%
[DCF] Terminal Value 73.26% ; FCFF base≈76.9m ; Y1≈68.1m ; Y5≈56.0m
[DCF] Fair Price = 3.51 (EV 896.6m - Net Debt 512.0m = Equity 384.6m / Shares 109.5m; r=8.35% [WACC [floored]]; 5y FCF grow -14.09% → 2.50% )
EPS Correlation: -21.80 | EPS CAGR: -3.78% | SUE: 0.72 | # QB: 0
Revenue Correlation: 78.85 | Revenue CAGR: 6.87% | SUE: 0.93 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.21 | Chg30d=+2.93% | Revisions=+0% | Analysts=5
EPS current Year (2026-12-31): EPS=0.69 | Chg30d=+1.36% | Revisions=+0% | GrowthEPS=+77.8% | GrowthRev=+44.5%
EPS next Year (2027-12-31): EPS=0.87 | Chg30d=-0.29% | Revisions=+0% | GrowthEPS=+25.4% | GrowthRev=+2.8%
[Analyst] Revisions Ratio: +0% (up=0, down=0)